Clinical trial Recruiting at 1 site Interventional Ages 3 to 6

LarySeal Clear versus Ambu Aura40 airway masks for preschool children

Official title: Evaluation of the Clinical Performance of Laryseal Clear Versus Ambu Aura 40 Laryngeal Mask Airway for Preschool Children

Run by Zagazig University · NCT07553247 · Data updated 2026-11-12

This test will see if the LarySeal Clear or the Ambu Aura40 laryngeal mask works better for keeping a secure airway in preschool children having short general anesthesia.

Quick facts

Study typeInterventional
Ages3 Years to 6 Years
SexAll
Enrollment54 (estimated)
SponsorZagazig University
Government
Locations1 site (Zagazig, Sharqia Province)
StatusRecruiting
StartedJune 25, 2025
Main results expectedJune 25, 2026
Study endsJuly 1, 2026
Registry record updatedApril 30, 2026
Trial IDNCT07553247 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Preschool children (ASA I–II) with normal airways scheduled for elective procedures under general anesthesia lasting under two hours whose parents or guardians consent are ideal candidates.

Probably not a fit

Children with expected difficult airways, congenital or acquired airway malformations, active upper respiratory infection, GERD, neuromuscular disorders, or those undergoing emergency surgery are excluded and unlikely to benefit from these results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Preschool children undergoing elective surgery under general anesthesia will be randomized to receive either the LarySeal Clear or the Ambu Aura40 laryngeal mask as the primary airway device. Approximately 48 participants (24 per group) plus an allowance for dropouts will be enrolled and surgeries are expected to last less than two hours. Device size and insertion will follow manufacturer guidelines, with failed third insertion attempt leading to endotracheal intubation and withdrawal. Key measurements include oropharyngeal leak pressure and standard intraoperative airway and ventilation parameters, with safety monitoring throughout.

Why it matters

Potential benefit: If successful, the trial could identify which mask gives a better airway seal and fewer complications for preschool children during anesthesia.

How similar studies have gone: Prior comparisons of supraglottic airway devices have reported differences in oropharyngeal leak pressures (e.g., Bell et al., Kaur et al.), but direct data specifically in preschool populations are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consent of patient's parents or guardians of the first degree.
* American Society of Anesthesiologists (ASA) Class I or II.
* BMI: 5-85% of the children of the same age and sex.
* Patients with mallampati grade I, II
* Type of anesthesia: general anesthesia expected to last for less than 2 hours.

Exclusion Criteria:

* Emergency surgeries.
* Expected difficult airway.
* Patients with congenital or acquired airway malformations.
* Patients with active upper respiratory tract infection at the time of surgery.
* Patients with history of gastroesophageal reflux disease (GERD).
* Patients with neuromuscular disorders affecting airway tone or respiratory function.

Where it's running

  • Zagazig university hospitals
    Zagazig, Sharqia Province, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.